CND Life Sciences
CND Life Sciences provides a diagnostic test and associated services that enable clinicians to detect, visualize, and quantify the phosphorylated form of alpha-synuclein in cutaneous nerve fibers. Its core offering—the Syn-One Test- leverages a minimally invasive skin-biopsy procedure to assist in the diagnostic evaluation of synucleinopathies such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. The company also offers laboratory services that apply immunofluorescence and intraepidermal nerve fibre density assessment to support clinical decision-making in neurodegenerative and autonomic disorders. In addition, it collaborates with biopharmaceutical organisations to support clinical trials through biomarker services and longitudinal assessment of nerve-based pathology.
Domain
cndlifesciences.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$3.0M
Founded
2016
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does CND Life Sciences use?+
CND Life Sciences uses 24 technologies including Autoptimize, Google Analytics, Google Tag Manager.
What industry is CND Life Sciences in?+
CND Life Sciences operates in the Biotechnology industry.
Where is CND Life Sciences based?+
CND Life Sciences is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026